GYPA and sarcoma: On the basis of this cohort, we aimed to (a) assess the validity of the original GPA index in sarcoma patients with brain metastases, and (b) develop an informative, sarcoma-specific GPA index (Sarcoma-GPA), to serve as a prognostic index for treatment decisions and outcomes analyses.